Imetelstat Achieved Prolonged, Continuous Transfusion Independence (TI) in Patients with Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndrome (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs) within the IMerge Phase 2 Study

Autor:	Uwe Platzbecker, Rami S. Komrokji, Pierre Fenaux, Amer M. Zeidan, Mikkael A. Sekeres, Michael Robert Savona, Yazan F. Madanat, Valeria Santini, Koen Van Eygen, Azra Raza, Ulrich Germing, Tymara Berry, Souria Dougherty, Sheetal Shah, Libo Sun, Fei Huang, Faye Feller, Ying Wan, Annat Ikin, Laurie Sherman
Rok vydání:	2022
Předmět:	Immunology Cell Biology Hematology Biochemistry
Zdroj:	Blood. 140:1106-1108
ISSN:	1528-0020 0006-4971
DOI:	10.1182/blood-2022-169050
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4d4dbf3061b90be898fd646750d3b205 https://doi.org/10.1182/blood-2022-169050 Zobrazit plný text záznamu